Moody National Bank Trust Division’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-114,081
Closed -$1.08M 499
2025
Q1
$1.08M Sell
114,081
-62,572
-35% -$632K 0.11% 211
2024
Q4
$1.99M Buy
176,653
+7,450
+4% +$131K 0.21% 108
2024
Q3
$4.79M Buy
169,203
+56,433
+50% +$1.45M 0.51% 36
2024
Q2
$2.16M Buy
112,770
+26,548
+31% +$678K 0.17% 79
2024
Q1
$2.83M Sell
86,222
-222
-0.3% -$7.08K 0.22% 55
2023
Q4
$2.86M Buy
86,444
+7,282
+9% +$206K 0.22% 56
2023
Q3
$2.16M Buy
79,162
+16,900
+27% +$470K 0.14% 119
2023
Q2
$1.89M Hold
62,262
0.13% 121
2023
Q1
$2.02M Buy
62,262
+21,256
+52% +$672K 0.17% 105
2022
Q4
$1.15M Buy
41,006
+7,000
+21% +$201K 0.1% 168
2022
Q3
$1.22M Buy
34,006
+7,300
+27% +$257K 0.13% 153
2022
Q2
$820K Buy
+26,706
New +$778K 0.09% 195

Other funds holding EVH

Moody National Bank Trust Division's EVH Position: Q2 2025 in Review

Moody National Bank Trust Division sold out of Evolent Health (EVH) in Q2 2025, closing a stake of 114,081 shares — an estimated $1.08M sold.

Moody National Bank Trust Division first reported a position in EVH in Q2 2022 and held it in 12 quarters. The position peaked at $4.79M in Q3 2024. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • Moody National Bank Trust Division reported no remaining Evolent Health position as of Q2 2025 after selling out during the quarter.
  • Moody National Bank Trust Division sold 114,081 Evolent Health shares in Q2 2025, an estimated $1.08M.
  • Moody National Bank Trust Division first reported a position in Evolent Health in Q2 2022 and held it in 12 quarters.
  • Moody National Bank Trust Division's Evolent Health position peaked at $4.79M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on Moody National Bank Trust Division's 13F filing for Q2 2025, filed 10 Jul 2025.